Teratogenicity and anticonvulsants: Lessons from neurology to psychiatry

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 9, 2007, Pages 29-33

  Viguera, Adele Casals ^a   Koukopoulos, Alexia ^a   Muzina, David J ^b   Baldessarini, Ross J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; MOOD STABILIZER; PHENOBARBITAL; PHENYTEK; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

BIPOLAR DISORDER; CLEFT FACE; CLEFT LIP; CLEFT LIP PALATE; CLINICAL PROTOCOL; CLINICAL RESEARCH; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; EPILEPSY; FETUS MALFORMATION; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; MONOTHERAPY; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REGISTER; REVIEW; RISK ASSESSMENT; SPINA BIFIDA; TERATOGENICITY; TREATMENT PLANNING; UROGENITAL TRACT MALFORMATION; ARTICLE; CONGENITAL MALFORMATION; DRUG CONTRAINDICATION; FEMALE; NEUROLOGY; PREGNANCY; PSYCHIATRY; STATISTICS;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; FEMALE; HUMANS; NEUROLOGY; PREGNANCY; PSYCHIATRY; REGISTRIES; RISK ASSESSMENT;

EID: 35349022175     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Licht EA, Sankar R, Gee M, et al. Pregnancies of women with epilepsy: a survey of practice patterns. Epilepsia 1995;36:154
2. Bromfield EB. Clinical use of anticonvulsants: a neurologist's perspective. Harv Rev Psychiatry 2003;11:257-268
3. Morrell MJ. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia 1996;37 (suppl 6):S34-S44
4. Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004;161:608-320
5. Viguera AC, Cohen LS, Bouffard S, et al. Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry 2002;159:2102-2104
6. American Academy of Neurology. AAN Guideline Summary for Clinicians: Management Issues for Women With Epilepsy. Available at: http://www.aan.com/ professionals/practice/index.cfm. Accessed Oct 31, 2006
7. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42:149-160
8. Viguera AC, Cohen LS, Reminick AM, et al. Anticonvulsants in pregnancy and lactation: differences in attitudes and practice patterns among neurologists vs psychiatrists [poster]. Presented at the 157th Annual Meeting of the American Psychiatric Association; May 1-6, 2004; New York, NY
9. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198
10. International Registry of Antiepileptic Drugs and Pregnancy. EURAP International. Available at http://www.eurapinternational.org. Accessed June 27, 2006
11. Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004;61:673-678
12. Cunnington M, Tennis P, for the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-960
13. UK Epilepsy and Pregnancy Register. Available at http://www. epilepsyandpregnancy.co.uk. Accessed July 27, 2006
14. Vajda FJ, Hitchcock A, Graham J, et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 2006;13:645-654
15. Wyszynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-965
16. Holmes LB, Wyszynski DF, et al. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy. Presented at the 46th annual meeting of the Teratology Society; June 24-29, 2006; Tucson, Ariz
17. Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007;164:342-345
18. Messenheimer JA, Wiel J. Thirteen year interim results from an International Observation Study of Pregnancy Outcomes Following Exposure to Lamotrigine. Presented at the 58th annual meeting of the American Academy of Neurology; April 1-8, 2006; San Diego, Calif
19. Tennis P, Eldridge RR, for the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002;43:1161-1167
20. Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70:15-21
21. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583
22. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32
23. The EMMES Corporation. Neurodevelopmental Effects of Antiepileptic Drugs (NEAD). 2006. Available http://www.neadstudy.com. Accessed June 19, 2006